This content is machine translated Guselkumab in psoriatic arthritis Early response predicted Recent analyses of a heterogeneous group of patients with active psoriatic arthritis (PsA) show that early treatment response with respect to skin psoriasis and enthesitis is a predictor of sustained…
View Post 6 min This content is machine translated Psoriatic arthritis Current therapy options The heterogeneity of psoriatic arthritis (PsA) suggests a high number of undiagnosed manifestations. Guidance is provided by the CASPAR classification criteria. Therapy concepts should be multimodal – supported by a…
View Post 5 min This content is machine translated Apremilast PDE4 inhibition in the treatment of inflammatory diseases. The PDE-4 inhibitor apremilast was discussed as a potential option in the treatment of psoriatic arthritis at this year’s ACR Congress in San Diego. Promising results show good efficacy both…
